Annals of Neurology

Article	Citations
	227
Reply to “Urinary α‐Synuclein for Parkinson's Detection: Key Limitations and Future Directions”	184
Issue Information	153
Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome	119
	112
Annals of Neurology: Volume 97, Number 1, January 2025	108
Furthering Female Faculty: An American Neurological Association/Association of University Professors of Neurology Perspective	107
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults	106
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers	92
The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology	90
Plasma Metabolites Link Dietary Patterns to Stroke Risk	86
Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic	84
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis	81
Frailty across Neurological Diseases: Why Sex and Gender Matter	80
Staufen Impairs Autophagy in Neurodegeneration	80
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	77
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment	73
Carotid Stent Fracture	73
Cerebrospinal Fluid Flow in Patients with Huntington's Disease	72
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis	70
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study	69
Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study	67
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease	65
Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials	65
Microneurography Reveals Unmyelinated Small Nerve Fiber Dysfunction in Long COVID	64

A Managed Care System with Telemedicine Support for Neurological Emergencies	62
Annals of Neurology: Volume 99, Number 5, May 2026	62
Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort	62
Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function	61
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis	60
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease	59
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study	58
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System	57
Biological Age Acceleration and Motoric Cognitive Risk Syndrome	56
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics	56
Network Localization of Awareness in Visual and Motor Anosognosia	56
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS	56
Cover Image	55
Annals of Neurology: Volume 94, Number S30, September 2023	54
Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt	53
RAN Translation of C9orf72‐Related Dipeptide Repeat Proteins in Zebrafish Recapitulates Hallmarks of Amyotrophic Lateral Sclerosis and Identifies Hypothermia as a Therap	53
Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials	53
Issue Information	53
Sensorimotor Cortex High Frequency Oscillations Characterize Motor Symptom Severity during Deep Brain Stimulation Surgery for Parkinson's Disease	51
Reply to “ AI: Need for Comparative Studies in Complex Neurologic Diagnosis”	50
Cross‐Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease	50
Sports Concussion and Category Mistakes	49
Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy	49
MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases	49
Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort	48
APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology	48
From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI	46
Illusions of Self‐Motion during Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Tremor	46
Issue Information	46
Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease	45
AI ‐Driven Mapping of Seizure Spread Patterns	45
GABRA1‐Related Disorders: From Genetic to Functional Pathways	44
GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy	43
Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia	43
Micro‐Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice	43
Correction: GATA1‐Mediated Transcriptional Regulation of the γ‐Secretase Activating Protein Increases Aβ Formation in Down Syndrome	42
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic Impairment	41
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study	41
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints	41
Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry	41
Ultrastructural Axon–Myelin Unit Alterations in Multiple Sclerosis Correlate with Inflammation	40
Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia	40
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome	39
Correction: Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia	39
Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy	39
Issue Information	38
Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score	38
NINDS Corner: The Helping to End Addiction Long‐Term Initiative and Pain Neurology	38
A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease	38
Bilateral Hearing Loss Caused by Inferior Collicular Infarction	37

	37
Reply to “Is There an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?”	37
Reply to “Letter on Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use”	37
Reply to “Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial”	37
Comment on Clinical, Prognostic, and Longitudinal Functional and Neuropsychological Features of West Nile Virus Neuroinvasive Disease in the United States: A Systematic Review and Meta‐Analysis	36
Reply to “Clinical Relevance of Genetic Variants in Juvenile Stroke Patients: A Plea for a Precise Classification”	36
Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies	36
Use of FDG ‐ PET in Balamuthia mandrillaris	36
Is there an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?	36
Issue Information	36
	35
Brain Iron Dysregulation in Iron Deficiency Anemia‐Related Restless Leg Syndrome Revealed by Neuron‐Derived Extracellular Vesicles: A Case–Control Study	35
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with HLA‐A*3303 and HLA‐DPB1*0501	35
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis	34
Extending the Interpretation of Biomarker Dynamics in SOD1 ‐ ALS Proteomics	34
Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype	34
Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study	34
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles	34
Signs of Cortical Inflammation in Migraine Measured with Quantitative Magnetic Resonance Imaging: A Registry for Migraine (REFORM) Study	33
Nocturnal Pulse Event Frequency Is Reduced in Multiple System Atrophy	33
Neuroimaging Biomarkers for Friedreich Ataxia: A Cross‐Sectional Analysis of the TRACK‐FA Study	33
Heart Rate Profiles During Exercise and Incident Parkinson's Disease	33
Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case‐Controlled Study	33
Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients	33
	33
Histopathological Correlates of Lobar Microbleeds in False‐Positive Cerebral Amyloid Angiopathy Cases	32
Automated Neuroprognostication Via Machine Learning in Neonates with Hypoxic‐Ischemic Encephalopathy	32
Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease	32
Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers	32
Prophylactic Fetal Creatine Supplementation Improves Post‐Asphyxial EEG Recovery and Reduces Seizures in Fetal Sheep: Implications for Hypoxic–Ischemic Encephalopathy	32
Genome‐Wide Analysis of Structural Variants in Parkinson Disease	32
Determinants of Infarct Core Growth During Inter‐hospital Transfer for Thrombectomy	32
Neocortical LBD in Women and Episodic Memory Decline in Men: Clarifying Sex Effects	32
Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3	32
Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease	32
Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence	31
Happy 75th National Institute of Neurological Disorders and Stroke	30
Issue Information	30
Trigeminal Trophic Syndrome from Lateral Medullary Stroke	30
	30
Issue Information – TOC	30
Issue Information	30
Extra Movements in Healthy People: Challenging the Definition and Diagnostic Practice of Tic Disorders	30
ANA Investigates: Atrial Fibrillation after Stroke	30
In Memoriam: Arthur Knight Asbury, MD (1928–2022)	30
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome	29
Correction to “Protective Effects of Socioeconomic Status and Lifestyle on Amyloid‐ and White Matter Hyperintensity‐Related Longitudinal Brain Atrophy and Cognitive Decline”	29
Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study	29
ANA Podcasts & Webinars: Genetics of Epilepsy	29
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations	29
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism	29
Correction: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy	29
Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study	29
Elevated Risk of Cerebral Arteriovenous Malformation Rupture during Pregnancy and Puerperium	29
CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T‐MRI	28
Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy	28
Reply to “The Role of EEG in Predicting Post‐Stroke Seizures and an Updated Prognostic Model ( SeLECT	28
Spoken Language Alterations can Predict Phenoconversion in Isolated Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Study	28
SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X‐Linked Intellectual Disability	28
Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R‐Related Disorder (CSF1R‐RD) in a Muri	28
Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type II	28
Search Strategies for Alzheimer Protector Genes	28
Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions	27
Adolescent Headache Due to Congenital Pelvic/Sacral Vascular Malformation	27
Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease	27
Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis	27
Issue Information	27
Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA ‐ DRB1	27
Annals of Neurology: Volume 96, Number 2, August 2024	26
Annals of Neurology: Volume 95, Number 4, April 2024	26
Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD	26
Annual Report from the Editor‐in‐Chief (2024)	26
NORSE, FIRES, and a Polygenic Trickle of Autoimmunity	26
Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System —A Multicenter Cohort Study in 163 P	26
Issue Information	26
Correction to Lyden P, Pryor KE, Coffey CS, et al. Final results of the RHAPSODY trial: a multi‐center, phase 2 trial using a continual reassessment	26
Cinematic Rendering of Extracranial to Intracranial Arterial Bypass	25
Reply to “Genetic Risk, Drug Regimens, and the Limits of Equitable Translation”	25
Relapses, Comorbidities, and Predictors of Outcome in Anti‐ GABA A Recep	25
Internal Carotid Artery Pseudoaneurysm and Unilateral Vocal Cord Paralysis Secondary to Parapharyngeal Space Abscess	25

Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke	25
AAV9‐ DARS2 Gene Therapy Rescues Phenotype in Leukoencephalopathy with Brainstem and Spinal Cord I	25
Brainstem Ischemic Syndrome in NF2‐Related Schwannomatosis	25
A Carotid Web with Atherosclerotic Plaque	25
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Stud	25
Risk‐Based EEG Allocation: The Next Step for SeLECT ‐ EEG	25
Activated Wake Systems in Narcolepsy Type 1	24
Polygenic Resistance to Blood Pressure Treatment and Stroke Risk: Insights from the All of Us Research Program	24
Sex Differences in Trends in Stroke Recurrence and Postrecurrence Mortality 2000–2020: Population‐Based Brain Attack Surveillance in Corpus Christi Project	24
	24
Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes	24
Diagnosing Epilepsy with Normal Interictal EEG Using Dynamic Network Models	24
Disease Progression in Charcot–Marie–Tooth Disease Related to MPZ Mutations: A Longitudinal Study	23
Emerging Management Challenges Posed by Atrial Fibrillation Detected After Stroke	23
Vessel Wall Imaging of a Carotid Web	23
Ribbon‐Like Sign in Convexity Subarachnoid Hemorrhage	23
De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Imp	23
Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability	23
“Don't Throw the Baby out with the Bathwater”	23
Social Health and Cognitive Change in Old Age: Role of Brain Reserve	22
Limbic Stimulation Drives Mania in STN‐DBS in Parkinson Disease: A Prospective Study	22
The Age at Onset of LRRK2 p. Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Ori	22
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	22
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers	22
Blood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory–Validation Study	22
Network Localization of Pediatric Lesion‐Induced Dystonia	22
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI‐ and Age‐Dependent Manner	22
Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas	22
Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI	22
Cinematic Rendering of Twig‐Like Middle Cerebral Artery	21
	21
Re‐Emergence of Poliovirus in the United States: Considerations and Implications	21
Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage	21
Issue Information	21
Reply to “Reassessing the Impact of Endovascular Thrombectomy on Cerebral Edema and Functional Outcomes”	21
Reply to “Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions”	21
	21
MuSK‐Myasthenia Gravis and Cancer	21
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions	21
Annals of Neurology: Volume 92, Number 3, September 2022	21
Fostering Academia‐Industry Partnerships to Facilitate Therapeutic Discoveries in Neurology: The Role of ANA as a Catalyst	21
Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept	21
Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions	21
	21
Divergent Causes and Convergent Mechanisms of SUDEP	20
MOG‐IgG‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination	20
Pragmatic Clinical Trials in Neurology	20
Networks Underlie Temporal Onset of Dysplasia‐Related Epilepsy: A MELD Study	20
Pathogenic Variants in RNU2‐2 , a Non‐coding Spliceosomal RNA , Cause a Distinctive Developmental and	20
Longitudinal Alterations of Cerebral Blood Flow in High‐Contact Sports	20
Cognitive Effects of Deep Brain Stimulation in GBA‐Related Parkinson Disease	20
Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants	20
Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study	20
Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo	20
Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies	20
Blood‐Based Proteomics for Adult‐Onset Focal Dystonias	20
Resilience to Endoplasmic Reticulum Stress Mitigates Membrane Hyperexcitability Underlying Late Disease Onset in a Murine Model of SCA6	20
Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy	20
AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems	20
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor	20
CSF ‐Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery	19
Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury	19
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia	19
Reply to “Letter to the Editor, Regarding ‘Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in	19
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy	19
Novel Monoclonal Antibody Detects Small Aβ Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media	19
Annals of Neurology: Volume 95, Number 3, March 2024	19
Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease	19
The Starry Cortex of Aβ‐Related Angiitis	19
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks	19
	19
Hyperreflective Foci in the Inner Nuclear Layer: Proof‐of‐Concept for an Optical Coherence Tomography Derived Microglia‐Related Marker in Multiple Sclerosis	19
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	19
Annals of Neurology: Volume 93, Number 4, April 2023	19
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk	19
Neuroprotection of Low‐Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats	19
Perimesencephalic Hemorrhage from A Superior Cerebellar Artery Dissection	18
Association of Mismatch Profiles and Clinical Outcome from Endovascular Therapy in Large Infarct: A Post‐Hoc Analysis of the ANGEL‐ASPECT Trial	18
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3	18
DNase1 RS1053874 Polymorphism is Associated with Early Neurological Recovery through NET Modulation and with Long‐Term Survival in Ischemic Stroke: A Prospective Cohort Study	18
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease	18
Proteomics and the Risk of Incident Embolic and Thrombotic Stroke	18
Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke	18
Longitudinal Retinal Changes in MOGAD	18
Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model	18
Reply to “Type I IFN Signature in NOTCH1‐Related Leukoencephalopathy”	18
Inhibition of Bone Morphogenetic Protein Signaling Prevents Tau Pathology in iPSC Derived Neurons and PS19 Mice	18
Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis	18
Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders	18
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial	18
	17
Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study	17
Characterizing Frontal Lobe Seizure Semiology in Children	17
	17
	17